For A German Medical Device Startup the Road to Being Acquired Went Through Houston Post author:Sam Post published:April 12, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+ August 16, 2017 Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017 Pfizer Hosts Annual Meeting Of Shareholders April 26, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017